Viscogliosi Brothers Watermark Holdings, LLC.
A proprietary Holding Company dedicated to creating Shareholder Value through capitalizing on regulatory driven high-barriers of entry and company building expertises along with creating predictable cash flows in the $500b low-correlated MedTech innovation universe.
About
Us
Our Vision
Becoming the World’s Leading Medical Devices / MedTech Investors; through a Holding Company dedicated to improving the Lives of the Human Race.
Our Mission
Increasing the Share Value of the Company by striking a balance between creating predictable cash flows and realizing capital growth opportunities.
Our History
VB Watermark (VBW) is founded in 2022 through partnership of 2 investment firms: Viscogliosi Brothers and Watermark Investments.
Founded in 1999, Viscogliosi Brothers (VB) is a dedicated family investment office with a 3.5x ROIC track record in the med tech/biologics industry. VB has accomplished 18 exits, at an average hold period of 5.5 years and distributed over $2.5b capital to its investment partners. MCRA, a VB subsidiary, is world-renowned clinical research organization that helps Companies obtain FDA approvals with a proprietary clientele pool exceeding 700 MedTech ventures. ​
VB has created a JV with Watermark Investments, one of its esteemed repetitive investors which is a multi-family office active in property, private equity, and credit instruments internationally. Monaut is a multi-strategy investment boutique bridging inter-disciplinary opportunities with its global network of investment institutions.
​The JV is essentially a Holding Company that capitalizes on MCRA’s clients prior to value inflection points on their path to regulatory approval. The Company is run with an endowment mentality with strong emphasis on generating current income and capital growth for its Shareholders.
